Congenital CMV Clinical Pathways

Congenital cytomegalovirus (CMV) is the most common congenital infection in the United States and is the number one cause of non-genetic hearing loss and can cause other long-term neurodevelopmental concerns. This pathway serves as guidance to the diagnosis and management of congenital CMV infections. 

Access our clinical pathways for congenital CMV treatment

• Congenital Cytomegalovirus (CMV)

_{Note: Use Google Chrome to access AgileMD. The links above will not work in other browsers.} 

About our Congenital CMV clinical pathways

• Congenital CMV is a complex condition that requires the input, oversight and care of a variety of disciplines and specialty providers  
• This clinical care pathway will serve to expedite referral to congenital CMV-associated specialties within CHCO for thorough and rapid evaluation to determine treatment eligibility and serve as a guide for long-term follow up with multiple specialties
• This pathway was created by our multidisciplinary team of content experts (including infectious diseases, audiology, ENT, developmental pediatric, ophthalmology, neurology, NICU, and hospital medicine) and process improvement professionals. Our teams reviewed available published literature, and they integrated local expert opinions when necessary.
• These pathways offer a standardized approach to risk stratification, diagnosis and postoperative management of acute appendicitis to guide the diagnosis and long-term care of patients with congenital CMV which can be years with multiple specialties.